gip glp 1 drugs The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion—A Review The GLP-1 Agonists and Obesity:
Description
Intensive weight loss intervention and cancer risk in adults with type 2 diabetes: analysis of the Look AHEAD randomized clinical trial
Glucagon-Like Peptide-1 Receptor Agonists Use Does Not Increase the Risk for Acute Pancreatitis and Is Associated With Lower Complications in Patients With Type 2 Diabetes Who Develop Acute Pancreatitis: A Multicenter Analysis Luis M
Can J Diabetes 2020;44:592-6
Research progress on the GIP/GLP-1 receptor coagonist tirzepatide, a rising star in type 2 diabetes
